Frontotemporal dementia or Frontotemporal Lobar Degeneration (FTLD) disease, as it is now known, has been making news recently due in large part to actor Bruce Willis’ diagnosis. At Benchmark at Rye, ...
San Diego, California — A newly identified cerebrospinal fluid (CSF) biomarker can accurately distinguish between 2 major subtypes of frontotemporal lobar degeneration (FTLD) in living patients, a ...
A variant of the TMEM106B gene, originally discovered in people with frontotemporal lobar degeneration with TDP-43 pathology, influences the TDP-43 protein in other neurodegenerative diseases too, ...
Just days after the first report of a highly eccentric translation mechanism in the major genetic forms of ALS and FTLD comes a second paper showing the same phenomenon. In the February 12 Neuron, ...
The protein β-arrestin-2 increases the accumulation of neurotoxic tau tangles, a cause several forms of dementia, by interfering with removal of excess tau from the brain, a new study by the ...
The mutated and aggregated protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit ...
Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years. This permanent loss of cognitive abilities affects daily function and can be caused by ...
The Dementia Consortium has awarded £305,000 of funding to a project identifying new therapeutics for Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar degeneration (FTLD). A team at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results